• About About
• Foundation Foundation
• Facilities Facilities
• Open positions Open positions
• Partners & Supporters Partners & Supporters
• Support us Support us
• Contact Contact

• Bioinformatics Core Unit
• Genomics Facility
• Preclinical Imaging Facility
• Experimental Pathology

• Overview Overview
• Research Programs
• Annual Reports Annual Reports
• Publications Publications

• Lymphoma and Genomics Lymphoma and Genomics
• Tumor Biology and Experimental Therapeutics Tumor Biology and Experimental Therapeutics

• Overview Overview
• Cancer Immunotherapy (Calcinotto) Cancer Immunotherapy (Calcinotto)
• Experimental Hematology (Rossi) Experimental Hematology (Rossi)
• Experimental Therapeutics (Catapano) Experimental Therapeutics (Catapano)
• Functional Cancer Genomics (Theurillat) Functional Cancer Genomics (Theurillat)
• Lymphoma Genomics (Bertoni) Lymphoma Genomics (Bertoni)
• Molecular Oncology (Alimonti) Molecular Oncology (Alimonti)
• Prostate Cancer Biology (Carbone) Prostate Cancer Biology (Carbone)
• Stem Cells and Cancer Stem Cells and Cancer

• Team
• Publications
• Partners
• Contact
• Characterization of the immune landscape of human breast and ovarian tumours
• A co-clinical approach to study the immune evolution of breast cancer
• The contribution of tumour-infiltrating myeloid cells in dictating tumour clonal evolution
• The role of the gut and tissue-associated microbiota in shaping the tumour-infiltrating immune response

• Contact
• Partners
• Publications
• Research projects
• Team
• Adaptation of chronic lymphocytic leukemia to ibrutinib
• Genetic and phenotypic attributes of splenic marginal zone lymphoma
• Circulating tumor DNA uncovers the genetic and clinical heterogeneity of classic Hodgkin lymphoma

• Team
• Contact
• Publications
• Partners
• Research projects
• Epigenetic regulators and the potential of epigenetic therapies
• Cancer stem cells and novel therapeutic approaches

• Contact
• Team
• Publications
• Research projects
• Partners
• Synthetic lethality between truncal mutations in SPOP and ERG in prostate cancer
• Prostate cancer transcriptome analysis reveals common path towards disease progression
• Antagonistic driver genes in prostate cancer in genomic models

• Team

• Partners
• Publications
• Contact
• Research projects
• Team
• Research Areas - Senescence and Senolytics
• Research Areas - Cell signaling and modelling
• Research Areas - Clinical trials
• Research Areas - Immuno-oncology
• Research Areas - Microbiota
• Research Areas - Cancer metabolism

• Partners
• Publications
• Team
• Research projects
• Epigenetics and progression of ERG fusion-positive prostate cancers
• Role of ESE3/EHF factor in prostate cancer
• Extracellular vesicles as mediators and biomarkers in prostate cancer
• Contact

• Contact
• Partners
• Publications
• Team

• Education and training Education and training
• PhD Program PhD Program

• News News
• Events Events